PL2911671T3 - Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera - Google Patents
Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem usheraInfo
- Publication number
- PL2911671T3 PL2911671T3 PL13848995T PL13848995T PL2911671T3 PL 2911671 T3 PL2911671 T3 PL 2911671T3 PL 13848995 T PL13848995 T PL 13848995T PL 13848995 T PL13848995 T PL 13848995T PL 2911671 T3 PL2911671 T3 PL 2911671T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrazolopyridazines
- methods
- hearing loss
- degenerative diseases
- loss associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718611P | 2012-10-25 | 2012-10-25 | |
| US201361775402P | 2013-03-08 | 2013-03-08 | |
| EP13848995.0A EP2911671B1 (en) | 2012-10-25 | 2013-10-25 | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| PCT/US2013/066939 WO2014066836A1 (en) | 2012-10-25 | 2013-10-25 | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2911671T3 true PL2911671T3 (pl) | 2018-11-30 |
Family
ID=50545356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13848995T PL2911671T3 (pl) | 2012-10-25 | 2013-10-25 | Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2911671B1 (pl) |
| JP (1) | JP6291502B2 (pl) |
| AU (1) | AU2013334139B2 (pl) |
| CA (1) | CA2889494C (pl) |
| ES (1) | ES2687854T3 (pl) |
| HK (1) | HK1214180A1 (pl) |
| HU (1) | HUE039970T2 (pl) |
| IL (1) | IL238288B (pl) |
| PL (1) | PL2911671T3 (pl) |
| WO (1) | WO2014066836A1 (pl) |
| ZA (1) | ZA201502655B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2701510B1 (en) | 2011-04-25 | 2017-02-15 | Usher III Initiative | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| US9227976B2 (en) | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| JP6290910B2 (ja) * | 2012-10-25 | 2018-03-07 | アッシャー・サード・イニシアティブ・インコーポレイテッド | ピラゾロピリダジンならびに網膜変性疾患およびアッシャー症候群に伴う聴力損失を処置するための方法 |
| WO2017045955A1 (en) * | 2015-09-14 | 2017-03-23 | Basf Se | Heterobicyclic compounds |
| JP7399870B2 (ja) | 2018-03-27 | 2023-12-18 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するための化合物 |
| JP7421507B2 (ja) * | 2018-06-27 | 2024-01-24 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するためのヘテロ環式およびヘテロアリール化合物 |
| WO2020161208A1 (en) | 2019-02-06 | 2020-08-13 | Syngenta Crop Protection Ag | Herbicidal fused pyridazine compounds |
| WO2020161209A1 (en) | 2019-02-06 | 2020-08-13 | Syngenta Crop Protection Ag | Herbicidal fused pyridazine compounds |
| WO2023139091A1 (en) * | 2022-01-19 | 2023-07-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Geralexin and uses thereof for the treatment of retinal degenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0206723D0 (en) * | 2002-03-21 | 2002-05-01 | Glaxo Group Ltd | Novel compounds |
| US20090306045A1 (en) * | 2005-12-22 | 2009-12-10 | Ira Mellman | Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease |
| US20100331297A1 (en) * | 2007-11-07 | 2010-12-30 | Foldrx Pharmaceuticals, Inc. | Modulation of protein trafficking |
| EP2701510B1 (en) * | 2011-04-25 | 2017-02-15 | Usher III Initiative | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| JP6290910B2 (ja) * | 2012-10-25 | 2018-03-07 | アッシャー・サード・イニシアティブ・インコーポレイテッド | ピラゾロピリダジンならびに網膜変性疾患およびアッシャー症候群に伴う聴力損失を処置するための方法 |
-
2013
- 2013-10-25 JP JP2015539868A patent/JP6291502B2/ja active Active
- 2013-10-25 HU HUE13848995A patent/HUE039970T2/hu unknown
- 2013-10-25 WO PCT/US2013/066939 patent/WO2014066836A1/en active Application Filing
- 2013-10-25 CA CA2889494A patent/CA2889494C/en active Active
- 2013-10-25 PL PL13848995T patent/PL2911671T3/pl unknown
- 2013-10-25 AU AU2013334139A patent/AU2013334139B2/en active Active
- 2013-10-25 EP EP13848995.0A patent/EP2911671B1/en active Active
- 2013-10-25 ES ES13848995.0T patent/ES2687854T3/es active Active
-
2015
- 2015-04-14 IL IL238288A patent/IL238288B/en active IP Right Grant
- 2015-04-20 ZA ZA2015/02655A patent/ZA201502655B/en unknown
-
2016
- 2016-03-02 HK HK16102422.6A patent/HK1214180A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL238288B (en) | 2018-04-30 |
| EP2911671A4 (en) | 2016-09-14 |
| JP6291502B2 (ja) | 2018-03-14 |
| EP2911671A1 (en) | 2015-09-02 |
| AU2013334139A1 (en) | 2015-04-30 |
| AU2013334139B2 (en) | 2017-08-03 |
| IL238288A0 (en) | 2015-06-30 |
| WO2014066836A1 (en) | 2014-05-01 |
| HUE039970T2 (hu) | 2019-02-28 |
| EP2911671B1 (en) | 2018-06-27 |
| CA2889494A1 (en) | 2014-05-01 |
| HK1214180A1 (zh) | 2016-07-22 |
| ES2687854T3 (es) | 2018-10-29 |
| CA2889494C (en) | 2018-12-18 |
| ZA201502655B (en) | 2017-11-29 |
| JP2015535257A (ja) | 2015-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201507790B (en) | Enhanced adoptive cell therapy | |
| GB2500915B (en) | Arrangement and method | |
| HK1214180A1 (zh) | 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法 | |
| HK1206666A1 (en) | Phototherapy devices and methods | |
| SG10201609812SA (en) | System and process for retina phototherapy | |
| EP2820527A4 (en) | DEVICE AND CORRESPONDING METHODS | |
| TWI561481B (en) | Glass manufacturing apparatus and methods | |
| EP2904647A4 (en) | DEVICE AND CORRESPONDING METHODS | |
| ZA201307961B (en) | Pyrazolopyridazines and methods for treating retinal-degenarative diseases and hearing loss associated with usher syndrome | |
| EP2828615A4 (en) | LASER GRAMMING SYSTEM AND METHOD | |
| HK1211875A1 (en) | Treating hearing loss | |
| EP2850678A4 (en) | APPARATUS AND ASSOCIATED METHODS | |
| GB201217070D0 (en) | Airflow modification patch and method | |
| GB201310158D0 (en) | Medico-surgical assemblies and means | |
| HK1214263A1 (zh) | 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法 | |
| EP2910675A4 (en) | MODIFIED FIBER AND METHOD FOR MANUFACTURING THE SAME | |
| GB2504303B (en) | Earphones and earplugs | |
| GB201213782D0 (en) | Process and dressing | |
| EP2928460A4 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY SKIN DISEASES | |
| EP2809285A4 (en) | HYPERBARE CHAMBER SYSTEM AND ASSOCIATED METHODS | |
| GB201213778D0 (en) | Process and dressng | |
| GB201221092D0 (en) | Assemblies and methods | |
| GB2519994B (en) | Assemblies and methods | |
| GB201211961D0 (en) | Methods and groups | |
| GB201208845D0 (en) | Methods and groups |